Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,237 across all filing types
Latest filing 2025-08-01 Declaration of Voting R…
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Please find attached herewith the disclosure of the Voting Result of the 40th AGM of Bliss GVS Pharma Limited held on Thursday, July 31, 2025, along with the Scrutinizer''s Report.
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed report on the voting results of the 40th Annual General Meeting (AGM) of Bliss GVS Pharma Limited held on July 31, 2025. It includes the Scrutinizer's Report on remote e-voting and electronic voting at the AGM, with detailed vote counts and percentages for various resolutions such as adoption of financial statements, dividend declaration, director re-appointment, and appointment of secretarial auditors. The document references compliance with SEBI regulations and the Companies Act, 2013, and is addressed to stock exchanges. The content is focused on the official disclosure of voting results and the Scrutinizer's certification of the voting process. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements (DVA)". The document length is substantial and contains detailed voting data, not just an announcement of a report, so it is not a Report Publication Announcement (RPA). It is not a management or financial report, nor a proxy solicitation or AGM presentation. Therefore, the correct classification is DVA with high confidence.
2025-08-01 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a detailed disclosure of the proceedings of the 40th Annual General Meeting (AGM) of Bliss GVS Pharma Limited held on July 31, 2025. It includes information about the meeting's conduct, attendees, agenda items, speeches by the Chairman and Managing Director, and voting procedures. The document references the Annual Report and Auditors' Report but does not contain the full financial statements or detailed financial data itself. It is a comprehensive summary of the AGM event rather than the Annual Report or any other financial report. Therefore, it fits the category of AGM Information (AGM-R). The document length (over 10,000 characters) and detailed content confirm it is not a mere announcement but the actual AGM proceedings.
2025-07-31 English
Please find attached herewith the proceedings of 40th Annual General Meeting of Bliss GVS Pharma Limited.
AGM Information Classification · 95% confidence The document is a detailed disclosure of the proceedings of the 40th Annual General Meeting (AGM) of Bliss GVS Pharma Limited held on July 31, 2025. It includes information about the meeting's conduct, attendees, agenda items, speeches by the Chairman and Managing Director, and procedural details such as e-voting and appointment of the scrutinizer. The document is not merely an announcement of the AGM or voting results but contains the full proceedings and discussions held during the AGM. It does not contain full financial statements or detailed financial analysis typical of an Annual Report (10-K) or Interim Report (IR), nor is it a transcript of a call or a regulatory filing. The content aligns with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. The document length (over 10,000 characters) and detailed content confirm it is the actual AGM proceedings report, not just an announcement or summary.
2025-07-31 English
Please find attached herewith copies of the Newspaper Publication regarding the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025.
Regulatory Filings
2025-07-31 English
Copy of Newspaper Publication
Regulatory Filings
2025-07-31 English
ESOP/ESOS/ESPS
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the grant of employee stock options under the company's Employee Stock Options Plan 2019. It references compliance with SEBI Listing Regulations and SEBI circulars, and provides detailed information about the stock options granted, including number of options, pricing formula, vesting schedule, and other terms. There is no financial performance data, earnings information, or management discussion. The content is an update on a capital-related event (grant of stock options) which affects the company's capital structure and employee compensation. This fits the category of Capital/Financing Update (CAP). The document length is about 4600 characters, which is consistent with a detailed announcement rather than a brief notice or a full report. Therefore, the appropriate classification is CAP with high confidence.
2025-07-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.